Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2025-12-25 @ 1:26 PM
NCT ID:
NCT04005859
Group ID:
EG001
Title:
EXPERIMENTAL: Exparel
Description:
EXPERIMENTAL: TAP block with liposomal bupivacaine will be given as an injection (Exparel)
Exparel: 2. Liposomal bupivacaine TAP block (experimental arm) n= 35
1. Block will be administered after induction of anesthesia and before incision by a specifically trained attending surgeon or surgical fellow with the colorectal service.
2. A single vial of liposomal bupivacaine (20 mL 1.3%, 13.3mg/mL, 266 mg) will be diluted in 50cc bupivacaine to a volume of 60cc prior to administration. This will be divided into 2 doses for bilateral TAP blocks.
3. The LB will be administered under ultrasound guidance in the transversus abdominis plain per manufacturer recommendations.
4. Adhesive tapes will be applied at the level of the TAP block puncture sites.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
25
Other Number Affected:
0
Other Number At Risk:
25
Study:
NCT04005859
Results Section:
NCT04005859
Adverse Events Module:
NCT04005859